Portfolio comparison
Immatics Biotechnologies vs Medtronic Minimed
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Immatics Biotechnologies
Patents indexed
3
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapygene_editingoncology
Top Patents3 enriched
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
US 12168044· 2024
Treating Liver Cancer with Specially Trained Immune Cells
US 11542303· 2023
How a Specific Peptide Boosts the Immune System Against Cancer
Activity by Decade
2010s1
2020s2
Company B
Medtronic Minimed
Patents indexed
2
Year range
2014 – 2018
Most recent
2018
biotechmedical_devicessoftwareconsumer_electronics
Top Patents2 enriched
US 8882665· 2014
How Continuous Glucose Monitors Estimate Blood Sugar Levels Accurately
US 9854998· 2018
How Devices Precisely Track Glucose Across Body Compartments
Activity by Decade
2010s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.